Montreal chosen as location for new Canadian Moderna vaccine-manufacturing plant |

Moderna has chosen Montreal as the placement for its Canadian mRNA vaccine-manufacturing plant, International Information has realized.

Prime Minister Justin Trudeau and Quebec Premier François Legault might be in Montreal on Friday for an official announcement.

A supply near the premier confirmed this info to International Information on Wednesday.

Learn extra:

New Moderna plant welcomed by public health experts but more details needed

Moderna CEO Stéphane Bancel was in Montreal in August 2021 when he introduced a memorandum of understanding had been reached with the federal authorities for the drug maker to construct a producing plant in Canada inside the subsequent two years, with vaccines being pumped out by 2024.

That will enable for the power to be constructed after which inspected and accredited by Well being Canada earlier than beginning manufacturing.

Story continues under commercial

Learn extra:

New Moderna plant opening in Canada, but we still don’t know where

The ability is anticipated to provide mRNA vaccines for a wide range of illnesses with a capability of 30 million doses of vaccine per yr.

Underneath the settlement unveiled in August, Canada wouldn’t solely get precedence entry to the doses, it might even have the flexibility to dictate what precisely the manufacturing unit makes, permitting it the pliability to answer new or rising threats.

“The Authorities of Canada has the fitting at its personal discretion to name the power to make a product that it needs,” Bancel mentioned on the announcement.

The situation of the brand new plant has but to be publicly introduced.

— with recordsdata from International Information’ Leslie Younger and the Canadian Press’ Mia Robinson

Click to play video: 'How mRNA vaccine technology could help fight other diseases'

How mRNA vaccine expertise may assist combat different illnesses

How mRNA vaccine expertise may assist combat different illnesses – Might 18, 2021


Story continues under commercial


© 2022 International Information, a division of Corus Leisure Inc.

Leave a Comment